Cargando…
Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive neurodegenerative disease, and only modest disease-modifying strategies have been established to date. Numerous clinical trials have been conducted in the past years, but have been severely hampered by the wide-ranging heterogeneity o...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921583/ https://www.ncbi.nlm.nih.gov/pubmed/35105727 http://dx.doi.org/10.1136/jnnp-2021-327503 |